Japan Grants Priority Review For Chugai's Herceptin For Gastric Cancer
This article was originally published in PharmAsia News
Executive SummaryJapan's Ministry of Health, Labor and Welfare granted priority review for Herceptin (trastuzumab) for HER2-positive advanced or recurrent gastric cancer
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.